Integra LifeSciences
IART
237 hedge funds and large institutions have $3.43B invested in Integra LifeSciences in 2020 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 84 increasing their positions, 84 reducing their positions, and 50 closing their positions.
35% more call options, than puts
Call options by funds: $1.33M | Put options by funds: $987K
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
1.15% more ownership
Funds ownership: 85.14% → 86.29% (+1.1%)
1% more capital invested
Capital invested by funds: $3.39B → $3.43B (+$32.9M)
0% more repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 84
10% less funds holding
Funds holding: 264 → 237 (-27)
54% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 50
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$114M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$22.7M |
| 3 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$13.4M |
| 4 |
CB
Cooke & Bieler
Philadelphia,
Pennsylvania
|
+$7.89M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$5.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
-$44.6M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$17.6M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$14.4M |
| 4 |
Millennium Management
New York
|
-$10.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$8M |
IART Hedge Fund Activity: Q3 2020 in Review
237 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2020, worth a combined $3.43B — up 0.97% from $3.39B a quarter earlier.
Sellers outnumbered buyers: 50 funds closed out of IART and 23 opened new positions — a net loss of 27 holders — while 84 trimmed existing stakes and 84 added.
The largest buyer was Wellington Management Group, adding an estimated $114M. The largest seller was Vaughan Nelson Investment Management, exiting entirely with an estimated $44.6M sold.
- 237 institutional investors held Integra LifeSciences (IART) as of Q3 2020, down from 264 in Q2 2020.
- Funds reported $3.43B of Integra LifeSciences stock for Q3 2020, up 0.97% quarter-over-quarter.
- 23 funds opened new Integra LifeSciences positions in Q3 2020 and 50 closed out, a net change of -27 holders.
- The largest Integra LifeSciences buyer in Q3 2020 was Wellington Management Group, an estimated $114M added.
- The largest Integra LifeSciences seller in Q3 2020 was Vaughan Nelson Investment Management, an estimated $44.6M sold.
Based on aggregated 13F filings for Q3 2020.